Covered recipient · General Payments record
MUSTAFA AL-CHALABI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2023–2024
$1,671.33
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,162.19 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $216.85 | 13 |
| LivaNova USA, Inc. | $188.29 | 5 |
| JAZZ PHARMACEUTICALS INC. | $161.16 | 2 |
| SK Life Science, Inc. | $156.65 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $114.42 | 1 |
| Lilly USA, LLC | $68.89 | 3 |
| EISAI INC. | $64.55 | 2 |
| Neurelis, Inc. | $63.85 | 3 |
| PFIZER INC. | $50.86 | 2 |
| CSL Behring | $43.68 | 2 |
| Genentech USA, Inc. | $32.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.88 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194400 | CMS |
| ABBVIE INC. | $22.52 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194402 | CMS |
| ABBVIE INC. | $27.51 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194404 | CMS |
| ABBVIE INC. | $17.65 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194406 | CMS |
| ABBVIE INC. | $21.97 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194408 | CMS |
| ABBVIE INC. | $15.48 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194410 | CMS |
| ABBVIE INC. | $5.50 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194412 | CMS |
| ABBVIE INC. | $0.83 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194414 | CMS |
| ABBVIE INC. | $16.88 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194416 | CMS |
| ABBVIE INC. | $2.20 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194418 | CMS |
| ABBVIE INC. | $12.15 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194420 | CMS |
| ABBVIE INC. | $19.19 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194422 | CMS |
| ABBVIE INC. | $26.09 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103194424 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $114.42 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144450346 | CMS |
| CSL Behring | $22.58 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134637469 | CMS |
| CSL Behring | $21.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134637473 | CMS |
| Eisai Inc. | $31.49 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110768613 | CMS |
| Eisai Inc. | $33.06 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110768615 | CMS |
| Genentech USA, Inc. | $32.99 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133077074 | CMS |
| JAZZ PHARMACEUTICALS INC. | $134.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150202162 | CMS |
| JAZZ PHARMACEUTICALS INC. | $27.04 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150202160 | CMS |
| Lilly USA, LLC | $22.68 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135228395 | CMS |
| Lilly USA, LLC | $29.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135227629 | CMS |
| Lilly USA, LLC | $16.71 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135228391 | CMS |
| LivaNova USA, Inc. | $21.76 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798313 | CMS |
| LivaNova USA, Inc. | $21.74 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798317 | CMS |
| LivaNova USA, Inc. | $111.23 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798315 | CMS |
| LivaNova USA, Inc. | $15.76 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798345 | CMS |
| LivaNova USA, Inc. | $17.80 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152798351 | CMS |
| Neurelis, Inc. | $24.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145630355 | CMS |
| Neurelis, Inc. | $14.33 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145630359 | CMS |
| Neurelis, Inc. | $25.12 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145630363 | CMS |
| PFIZER INC. | $26.59 | 11/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131492015 | CMS |
| PFIZER INC. | $24.27 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131547520 | CMS |
| SK Life Science, Inc. | $122.08 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154145024 | CMS |
| SK Life Science, Inc. | $34.57 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154145026 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.